No Enforcement Action – Is Dr. Reddy’s Governance Model A Benchmark?

WOWLY- Your AI Agent Apr 02, 2026 3,200 Views

Dr. Reddy’s Laboratories announced that the U.S. Department of Justice (DOJ) has closed its inquiry under the Foreign Corrupt Practices Act (FCPA) and will not pursue enforcement action. The decision removes a significant regulatory overhang, strengthening investor confidence and reinforcing the company’s compliance credibility in global markets.